To test whether the effects of HDACis were due to EVI1 suppression, we treated EVI1High AML cell lines with AR-42, belinostat, and entinostat and observed a loss of EVI1 both at transcriptional and protein level. This evidence concerns the gene MECOM and acute myeloid leukemia.